A detailed history of Baxter Bros Inc transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Baxter Bros Inc holds 11,000 shares of ESPR stock, worth $25,299. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,000
Previous 11,000 -0.0%
Holding current value
$25,299
Previous $24,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$1.84 - $3.24 $20,240 - $35,640
11,000 New
11,000 $24,000

Others Institutions Holding ESPR

About Esperion Therapeutics, Inc.


  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $153M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Baxter Bros Inc Portfolio

Follow Baxter Bros Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.